Interventional Oncology Market Size to Hit USD 6.73 Billion by 2035

Interventional Oncology Market Size 2026 to 2035

The global interventional oncology market size was valued at USD 2.94 billion in 2025 and is projected to grow from USD 3.19 billion in 2026 to approximately USD 6.73 billion by 2035, registering a CAGR of 8.63% during the forecast period. The increasing incidence of cancer and the growing demand for minimally invasive procedures are key factors fueling market expansion.

Introduction

The global interventional oncology market is experiencing significant growth, driven by the rising burden of cancer worldwide and the increasing adoption of minimally invasive treatment approaches. Interventional oncology, a specialized branch of oncology, focuses on image-guided procedures such as ablation and embolization to diagnose and treat tumors with high precision and minimal damage to surrounding tissues.

Read Also: Analog AI Chip Market

Key Takeaways

• North America dominated the market in 2025.
• Asia Pacific is expected to witness the fastest growth.
• Ablation therapies led the market by technique in 2025.
• Embolization therapies are projected to grow at the fastest rate.
• Vascular interventions accounted for a significant share in 2025.
• Tumor ablation is expected to grow at the highest CAGR.
• Liver cancer dominated the application segment.
• Lung cancer is projected to grow significantly.
• Hospitals held the largest share by end-user.
• Specialty clinics are expected to grow rapidly.

Market Overview

Interventional oncology offers advanced, minimally invasive treatment options for cancer patients through image-guided techniques. These procedures enable precise targeting of tumors, resulting in fewer complications, shorter hospital stays, and faster recovery compared to traditional surgical methods.

The market is expanding due to:

• Rising global cancer incidence
• Growing preference for minimally invasive treatments
• Advancements in imaging and therapeutic technologies
• Improved reimbursement frameworks
• Increased investments in oncology research

How is AI Transforming the Interventional Oncology Market?

Artificial intelligence (AI) is playing a transformative role in interventional oncology by enhancing diagnostic accuracy and treatment outcomes. AI-powered imaging systems assist clinicians in identifying and characterizing tumors more precisely, enabling better treatment planning.

Key benefits of AI integration include:

• Improved tumor detection and segmentation
• Personalized treatment planning
• Predictive analytics for treatment outcomes
• Enhanced procedural accuracy through robotic assistance
• Data-driven clinical decision-making

Key Market Trends

Rising Demand for Minimally Invasive Treatments

Patients are increasingly opting for less invasive procedures such as ablation and embolization, which offer reduced complications and faster recovery.

Integration with Combination Therapies

Interventional oncology is being combined with chemotherapy, immunotherapy, and radiation therapy to improve clinical outcomes and expand treatment applications.

Shift Toward Outpatient Care

The growing adoption of outpatient and ambulatory surgical centers is reducing healthcare costs and improving patient accessibility.

Personalized Cancer Treatments

The development of targeted therapies such as drug-eluting beads and precision embolic agents is enabling customized treatment approaches.

Segment Insights

Technique Insights

Ablation Therapies Lead the Market

The ablation therapies segment dominated the market in 2025 due to its high precision and minimally invasive nature. Techniques such as:

• Radiofrequency ablation (RFA)
• Microwave ablation (MWA)
• Cryoablation
• Laser ablation

are widely used for treating tumors in organs like the liver, lung, kidney, and bone.

Embolization Therapies to Grow Rapidly

The embolization segment is expected to grow at the fastest CAGR, driven by its effectiveness in treating liver cancers. Procedures such as transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) allow targeted drug delivery while minimizing systemic toxicity.

Procedure Insights

Vascular Interventions Dominate

Vascular interventions held the largest market share in 2025, supported by increasing use in liver cancer treatments. These procedures enable direct delivery of therapeutic agents to tumors via catheter-based systems.

Tumor Ablation Shows Strong Growth

Tumor ablation is expected to grow rapidly due to technological advancements and its effectiveness in treating early-stage and inoperable tumors.

Application Insights

Liver Cancer Leads the Market

The liver cancer segment dominated in 2025 due to the high prevalence of hepatocellular carcinoma and metastatic liver tumors. Interventional techniques such as TACE, TARE, and ablation are widely used for liver malignancies.

Lung Cancer to Witness Significant Growth

The lung cancer segment is expected to grow at a strong pace, driven by rising incidence and increasing adoption of minimally invasive ablation techniques.

End-User Insights

Hospitals Hold the Largest Share

Hospitals accounted for the largest market share due to advanced infrastructure, availability of skilled professionals, and comprehensive cancer care facilities.

Specialty Clinics Growing Rapidly

Specialty clinics are expected to grow at the fastest rate due to:

• Personalized care offerings
• Reduced waiting times
• Increasing demand for outpatient procedures

Regional Insights

North America Leads the Market

North America dominated the global interventional oncology market in 2025 due to:

• Advanced healthcare infrastructure
• High cancer prevalence
• Strong reimbursement policies
• Presence of leading market players

The regional market is projected to grow from USD 1.23 billion in 2025 to USD 2.86 billion by 2035, at a CAGR of 8.80%.

U.S. Market Growth

The U.S. market is expected to grow from USD 922.5 million in 2025 to USD 2,159.3 million by 2035, driven by increasing adoption of minimally invasive procedures and advanced diagnostic technologies.

Asia Pacific: Fastest Growing Region

Asia Pacific is expected to register the fastest growth due to:

• Rising cancer burden in countries like China, India, and Japan
• Increasing healthcare investments
• Growing medical tourism
• Expanding private healthcare infrastructure

Europe: Steady Growth

Europe is witnessing notable growth due to:

• Aging population
• Rising cancer incidence
• Strong government support for early diagnosis
• Advancements in imaging technologies

Competitive Landscape

The interventional oncology market is highly competitive, with key players focusing on innovation, partnerships, and acquisitions.

Key Companies Include:

• Medtronic plc
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Teleflex Incorporated
• Cook Medical
• AngioDynamics Inc.
• Stryker Corporation
• Profound Medical
• Terumo Corporation
• Siemens Healthineers

Recent Developments

• In December 2024, AngioDynamics received FDA approval for its NanoKnife System for prostate tissue ablation.
• In February 2024, Profound Medical partnered with Siemens Healthineers to integrate TULSA-PRO with MRI systems.
• In September 2024, Stryker Corporation acquired care.ai to strengthen its AI-driven healthcare solutions.

Market Segmentation

By Techniques

• Ablation Therapies
• Embolization Therapies
• Biopsy Techniques
• Targeted Therapy Delivery Systems
• Image-Guided Procedures

By Procedure

• Tumor Ablation
• Tumor Biopsy
• Vascular Interventions
• Palliative Care

By Application

• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Prostate Cancer
• Breast Cancer
• Others

By End-User

• Hospitals
• Specialty Clinics
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Conclusion

The interventional oncology market is poised for strong growth over the coming decade, fueled by rising cancer incidence, technological advancements, and increasing demand for minimally invasive treatment options. The integration of AI, expansion of outpatient care, and development of targeted therapies are expected to further accelerate market growth.

As healthcare systems continue to evolve, interventional oncology will play a crucial role in delivering precise, effective, and patient-centric cancer care worldwide.

Get Sample PDF: https://www.precedenceresearch.com/checkout/7798